Malta - English - Medicines Authority

merck sharp & dohme limited - atorvastatin; ezetimibe - film-coated tablet - atorvastatin 10 mg; ezetimibe 10 mg - lipid modifying agents

Malta - English - Medicines Authority

merck sharp & dohme limited - atorvastatin; ezetimibe - film-coated tablet - atorvastatin 20 mg; ezetimibe 10 mg - lipid modifying agents

Malta - English - Medicines Authority

merck sharp & dohme limited - atorvastatin; ezetimibe - film-coated tablet - atorvastatin 40 mg; ezetimibe 10 mg - lipid modifying agents

Malta - English - Medicines Authority

merck sharp & dohme limited - atorvastatin; ezetimibe - film-coated tablet - atorvastatin 80 mg; ezetimibe 10 mg - lipid modifying agents

Ireland - English - HPRA (Health Products Regulatory Authority)

merck sharp and dohme limited - ezetimibe, micronized, atorvastatin, atorvastatin calcium trihydrate - film coated tablet - 10 /10 milligram - hmg coa reductase inhibitors in combination with other lipid modifying agents

Ireland - English - HPRA (Health Products Regulatory Authority)

merck sharp and dohme limited - ezetimibe, micronized, atorvastatin calcium trihydrate - film coated tablet - 10 / 20 milligram - hmg coa reductase inhibitors in combination with other lipid modifying agents

Ireland - English - HPRA (Health Products Regulatory Authority)

merck sharp and dohme limited - ezetimibe, micronized, atorvastatin, atorvastatin calcium trihydrate - film coated tablet - 10 / 40 milligram - hmg coa reductase inhibitors in combination with other lipid modifying agents

Ireland - English - HPRA (Health Products Regulatory Authority)

merck sharp and dohme limited - ezetimibe, micronized, atorvastatin, atorvastatin calcium trihydrate - film coated tablet - 10 / 80 milligram - hmg coa reductase inhibitors in combination with other lipid modifying agents

Israel - English - Ministry of Health

organon pharma israel ltd., israel - atorvastatin as calcium trihydrate; ezetimibe - film coated tablets - atorvastatin as calcium trihydrate 10 mg; ezetimibe 10 mg - atorvastatin and ezetimibe - - prevention of cardiovascular eventsatozet is indicated to reduce the risk of cardiovascular events in patients with coronary heart disease (chd) and a history of acute coronary syndrome (acs), either previously treated with a statin or not.- hypercholesterolaemiaatozet is indicated as adjunctive therapy to diet for use in adults with primary (heterozygous familial and non-familial) hypercholesterolaemia or mixed hyperlipidaemia where use of a combination product is appropriate• patients not appropriately controlled with a statin alone• patients already treated with a statin and ezetimibe- homozygous familial hypercholesterolaemia (hofh)atozet is indicated as adjunctive therapy to diet for use in adults with hofh. patients may also receive adjunctive treatments (e.g., low-density lipoprotein [ldl] apheresis).

Israel - English - Ministry of Health

organon pharma israel ltd., israel - atorvastatin as calcium trihydrate; ezetimibe - film coated tablets - atorvastatin as calcium trihydrate 20 mg; ezetimibe 10 mg - atorvastatin and ezetimibe - - prevention of cardiovascular eventsatozet is indicated to reduce the risk of cardiovascular events in patients with coronary heart disease (chd) and a history of acute coronary syndrome (acs), either previously treated with a statin or not.- hypercholesterolaemiaatozet is indicated as adjunctive therapy to diet for use in adults with primary (heterozygous familial and non-familial) hypercholesterolaemia or mixed hyperlipidaemia where use of a combination product is appropriate• patients not appropriately controlled with a statin alone• patients already treated with a statin and ezetimibe- homozygous familial hypercholesterolaemia (hofh)atozet is indicated as adjunctive therapy to diet for use in adults with hofh. patients may also receive adjunctive treatments (e.g., low-density lipoprotein [ldl] apheresis).